Document Detail


Hypertension and cardiac arrhythmias.
MedLine Citation:
PMID:  17896999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Arterial hypertension is a widespread disease and one of important yet under-recognized and under-treated causes of atrial and ventricular arrhythmias. Hypertrophy of cardiac muscle in hypertensive patients is characterized not only by increased myocardial mass, but also by proliferation of fibrous tissue and decreased intercellular coupling, that lead to inhomogeneity of electrical properties and propensity to various arrhythmias. Many trials show the importance of treating hypertension in order to restore normal myocardial function and decrease the number of premature beats, runs of ventricular tachycardia, and attacks of atrial fibrillation. To date, the most convincing data are collected regarding the importance of blockade of renin-angiotensin-aldosterone system (RAAS) in order to avoid arrhythmias in arterial hypertension. Other antihypertensive drug classes (eg beta-blockers, calcium antagonists) are also useful, and investigational compounds that aim at regression of hypertrophy are under search. Polymorphism of genes coding the function of RAAS, pathways of synthesis and degradation of proteins and other cardiac and extracardiac systems involved in regulation of blood pressure, are recognized as promising targets for research.
Authors:
Audrius Aidietis; Aleksandras Laucevicius; Germanas Marinskis
Related Documents :
16970729 - The cardiovascular effects of arteriovenous fistulas in chronic kidney disease: a cause...
17011239 - Carcinoid crisis and reversible right ventricular dysfunction after embolization in unt...
2534139 - Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hy...
16380549 - Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin i...
18377459 - Left ventricular dysfunction and mortality in adult patients with eisenmenger syndrome.
2149059 - Left ventricular dilatation and failure post-myocardial infarction: pathophysiology and...
23520169 - Minimal extracorporeal circulation reduces the incidence of postoperative major adverse...
16923409 - Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononu...
19628529 - Mechanoenergetic function and troponin t release following cardioplegic arrest induced ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current pharmaceutical design     Volume:  13     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2007  
Date Detail:
Created Date:  2007-09-27     Completed Date:  2007-11-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  2545-55     Citation Subset:  IM    
Affiliation:
Centre of Cardiology and Angiology, Vilnius University Hospital Santariskiu Klinikos, Santariskiu str. 2, Vilnius 08661, Lithuania.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arrhythmias, Cardiac / drug therapy,  etiology*,  metabolism*
Humans
Hypertension / complications*,  drug therapy,  metabolism*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hypertension, anti-hypertensive therapy and neoplasia.
Next Document:  Management of hypertension in relation to acute coronary syndromes and revascularisation.